JENNIFER CORBIN: Open Payments
NPI 1902055619 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 80 payments from 16 companies in 2025. Trend: 2023 $1,536 · 2024 $1,249 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $353 |
| UCB, Inc. | 14 | $207 |
| Lilly USA, LLC | 7 | $153 |
| Janssen Biotech, Inc. | 12 | $153 |
| Regeneron Healthcare Solutions, Inc. | 5 | $124 |
| Galderma Laboratories, L.P. | 5 | $94 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Organon LLC | 2 | $32 |
| Arcutis Biotherapeutics, Inc. | 2 | $28 |
Products named: Bimzelx, SKYRIZI, RINVOQ, TREMFYA, TALTZ, DUPIXENT, AKLIEF, LIBTAYO.
Industry payments across WA — which companies pay providers there.
